Effects of glucocorticoids on interstitial glucose concentrations in individuals with hematologic cancer and without known diagnosis of diabetes: a pilot study.

Marcos Tadashi Kakitani Toyoshima Priscilla Cukier Alexandre Barbosa Câmara de Souza Juliana Pereira Ana Oliveira Hoff Marcia Nery

Published in: Einstein (Sao Paulo, Brazil) (2022)

This pilot study was the first to evaluate interstitial glucose levels in non-diabetic individuals using glucocorticoids in treatment of hematologic cancer. Glucocorticoid use during chemotherapy significantly increases interstitial glucose levels in these patients.

Keyphrases

papillary thyroid
end stage renal disease
type diabetes
blood glucose
squamous cell
ejection fraction
newly diagnosed
cardiovascular disease
chronic kidney disease
peritoneal dialysis
adipose tissue
metabolic syndrome
radiation therapy
rectal cancer
patient reported